B CELL LYMPHOMA
Clinical trials for B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a daily pill keep lymphoma away after CAR-T? new study aims to find out.
Disease control Not yet recruitingThis study tests whether taking zanubrutinib (a targeted pill) after CAR-T cell therapy can help keep non-Hodgkin B-cell lymphoma under control for longer. About 40 adults who have already had or are about to have CAR-T therapy will take zanubrutinib as maintenance. The main goal…
Matched conditions: B CELL LYMPHOMA
Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 01, 2026 15:28 UTC
-
New Immune-Boosting drug targets tough lymphomas in early trial
Disease control Not yet recruitingThis early-stage study tests a new drug called LY4152199 in adults with B-cell lymphoma that has come back or not responded to prior treatments. The drug is designed to help the body's immune cells find and attack cancer cells. The main goals are to find the safest dose and see i…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
Double-Pronged CAR t cells take on tough blood cancers
Disease control Not yet recruitingThis early-phase trial tests a new type of CAR T cell therapy that targets two proteins (CD19 and CD20) on cancer cells. It is for adults with B-cell leukemia or lymphoma who have run out of standard treatments, including commercial CAR T cells. The main goal is to check safety a…
Matched conditions: B CELL LYMPHOMA
Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 01, 2026 15:23 UTC